| Schedule of computation of basic and diluted loss per common share |
| | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | September 30, | | September 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | | | (in thousands, except for per-share data) | Net loss from continuing operations | | $ | (3,763) | | $ | (3,585) | | $ | (10,333) | | $ | (11,248) | Net income (loss) from discontinued operations | | | 9,252 | | | (172) | | | 8,087 | | | 640 | Net income (loss) | | | 5,489 | | | (3,757) | | | (2,246) | | | (10,608) | Deemed dividends | | | — | | | (3,677) | | | — | | | (7,711) | Net income (loss) available to common shareholders | | $ | 5,489 | | $ | (7,434) | | $ | (2,246) | | $ | (18,319) | | | | | | | | | | | | | | Weighted average common shares outstanding - Basic | | | 3,541,337 | | | 4,223 | | | 1,301,656 | | | 2,617 | Dilutive effect of outstanding warrants, options and RSUs (1) | | | 6,476,494 | | | 2,959 | | | 2,138,206 | | | 2,053 | Dilutive effect of series A convertible preferred shares | | | 1,870,657 | | | - | | | 630,405 | | | - | Denominator for diluted EPS | | | 11,888,488 | | | 7,182 | | | 4,070,266 | | | 4,670 | | | | | | | | | | | | | | | | | | | | | | | | | | | Basic loss per common share from continuing operations | | $ | (1.06) | | $ | (848.84) | | $ | (7.94) | | $ | (4,297.69) | Basic income (loss) per common share from discontinued operations | | | 2.61 | | | (40.77) | | | 6.21 | | | 244.44 | Basic loss per common share from deemed dividends | | | — | | | (870.65) | | | — | | | (2,946.25) | Basic income (loss) per common share | | $ | 1.55 | | $ | (1,760.26) | | $ | (1.73) | | $ | (6,999.50) | | | | | | | | | | | | | | Diluted loss per common share from continuing operations | | $ | (1.06) | | $ | (848.84) | | $ | (7.94) | | $ | (4,297.69) | Diluted income (loss) per common share from discontinued operations | | | 0.78 | | | (40.77) | | | 1.99 | | | 137.00 | Diluted loss per common share from deemed dividends | | | — | | | (870.65) | | | — | | | (2,946.25) | Diluted income (loss) per common share | | $ | (0.28) | | $ | (1,760.26) | | $ | (5.95) | | $ | (7,106.94) | | | | | | | | | | | | | | | | | | | | | | | | | | | Anti-dilutive shares are as follows as of September 30: | | | | | | | | | | | | | Warrants (excluding pre-funded) | | | 11,422,790 | | | 1,119,424 | | | 11,422,790 | | | 1,119,424 | Options | | | 25,861 | | | 2 | | | 25,861 | | | 2 | Restricted stock units | | | 8,624 | | | 51 | | | 8,624 | | | 51 | | | | 11,457,275 | | | 1,119,477 | | | 11,457,275 | | | 1,119,477 |
| (1) | See Note 10 “Capital Raise and Warrant for Common Stock” for description of Zero Exercise Price warrants |
|